Published in Gesundheitswesen on September 01, 1992
Sequential recovery of NK cell receptor repertoire after allogeneic hematopoietic SCT. Bone Marrow Transplant (2010) 1.44
Imatinib therapy prior to myeloablative allogeneic stem cell transplantation. Bone Marrow Transplant (2005) 0.95
Impact of activating killer immunoglobulin-like receptor genotype on outcome of unrelated donor-hematopoietic cell transplantation. Transplant Proc (2006) 0.89
Association of KIR2DS4 and its variant KIR1D with leukemia. Leukemia (2008) 0.84
Addition of cladribine to induction/consolidation regimen does not impair peripheral blood stem cell mobilization and bone marrow harvest for autotransplantation in acute myeloid leukemia patients. Transplant Proc (2005) 0.80
Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT. Bone Marrow Transplant (2008) 0.79
Lymphocyte reconstitution after allogeneic bone marrow transplantation in a previously thymectomized patient--no evidence of extrathymic T-cell maturation. Bone Marrow Transplant (2007) 0.78
Beta-2-microglobulin level predicts outcome following autologous hematopoietic stem cell transplantation in patients with multiple myeloma. Transplant Proc (2007) 0.77
[Algodystrophic syndromes]. Wiad Lek (1974) 0.75
[Clinical evaluation of the preparation Palitrex (cephalexin monohydrate)]. Wiad Lek (1982) 0.75
[Kay's test and gastric mucosa biopsy in Addison's disease]. Pol Tyg Lek (1973) 0.75
[Excretion of beta-2-microglobulin and Tamm-Horsfall protein in patients undergoing a conditioning regimen before bone marrow transplantation]. Pol Arch Med Wewn (1994) 0.75
[Blood gas analysis of forearm veins--at rest and after exercise of forearm muscles and laser Doppler flowmetry of skin on the back of the palm--use in evaluation of microcirculation in diabetes type 2]. Pol Arch Med Wewn (2001) 0.75
[Value of ultrasonic examination of the abdominal cavity in treatment monitoring in malignant lymphoma]. Pol Arch Med Wewn (1986) 0.75
[Ultrasonographic studies of lymph nodes and parenchymal organs of the abdominal cavity in malignant lymphomas]. Pol Arch Med Wewn (1986) 0.75
Unrelated donor bone marrow transplantation with treosulfan-based myeloablative conditioning for paroxysmal nocturnal hemoglobinuria--successful treatment despite multiple transplant-related risk factors for hemolysis including major Kidd group incompatibility. Bone Marrow Transplant (2006) 0.75
[Use of cardiopulmonary bypass decreases leukocyte count and activation of the complement system]. Kardiol Pol (1992) 0.75
[Primary amyloidosis of the lymph nodes]. Pol Tyg Lek (1982) 0.75
[Assessment of adrenal gland reserve in patients with ulcerative colitis]. Pol Tyg Lek (1977) 0.75
[Central nervous system relapses in acute lymphoblastic leukemia and different methods of prophylaxis]. Acta Haematol Pol (1995) 0.75
[Primary forms of extralymphatic non-Hodgkin's lymphoma]. Pol Tyg Lek (1996) 0.75
[Results of induction treatment with idarubicin for acute nonlymphoblastic leukemia in adults]. Acta Haematol Pol (1994) 0.75
Post-transplant induction of donor-type anti-RhD antibodies production shortly followed by complete hemolysis of recipient-type erythrocytes in RhD-mismatched allogeneic bone marrow recipient. Bone Marrow Transplant (2006) 0.75
Allogeneic and autologous bone marrow transplantation in single centre experience. Bone Marrow Transplant (1998) 0.75
Autologous peripheral blood stem and progenitor cells transplantation as a valid treatment approach in recurrent, refractory lymphoma. Arch Immunol Ther Exp (Warsz) (1995) 0.75
[Sucrose test in leukemias]. Acta Haematol Pol (1977) 0.75
Electrophoretic mobility of blood lymphocytes stored at -196 degrees. Arch Immunol Ther Exp (Warsz) (1984) 0.75
Immunomagnetic method of CD34(+) cell separation. Transplant Proc (1996) 0.75
Biocompatibility of extracorporeal circulation with autooxygenation. Eur J Cardiothorac Surg (1992) 0.75
Ifosfamide, etoposide, epirubicine, and G-CSF: an effective mobilization regimen for PBSCT in heavily pretreated patients. Transplant Proc (2000) 0.75
Improved biocompatibility of extracorporeal circulation by the use of auto-oxygenation instead of artificial oxygenator in perfusion circuit. Nephrol Dial Transplant (1991) 0.75
[Patients with dementia in nursing homes]. Pflege Aktuell (1994) 0.75
[Arylsulfatase of peripheral blood leukocytes in patients with selected proliferative diseases of the hematopoietic system, malignant neoplasms in other organs and lupus erythematosus]. Pol Arch Med Wewn (1984) 0.75
[Marfan syndrome in the light of observed cases]. Wiad Lek (1984) 0.75
[Ultrasonographic studies in evaluating the degree of advancement of stomach cancer]. Pol Tyg Lek (1987) 0.75
[Value of ultrasonographic examination in monitoring the treatment of advanced cancer of the stomach]. Pol Przegl Radiol (1989) 0.75
Allogeneic transplantation of selected peripheral CD34+ cells with controlled CD3+ cells add-back in high-risk patients. Transplant Proc (2004) 0.75
[Techniques of positive isolation of CD34(+) cells. Personal experience with the immunomagnetic method]. Acta Haematol Pol (1996) 0.75
[Autologous peripheral blood stem cell transplantation as an effective treatment for recurrent Hodgkin's disease]. Pol Merkur Lekarski (1997) 0.75
[Venous blood gas analysis sampled from the basilic vein before and after exercise of the antebrachial muscles--preliminary evaluation of estimated stability parameters]. Pol Arch Med Wewn (1999) 0.75
Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patients. Transplant Proc (2002) 0.75